Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,965 | 372 | 98.5% |
| Education | $75.00 | 1 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,377 | 120 | $0 (2024) |
| Alkermes, Inc. | $701.67 | 60 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $573.67 | 53 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $563.93 | 31 | $0 (2024) |
| Lundbeck LLC | $341.20 | 24 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $324.96 | 21 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $227.07 | 15 | $0 (2024) |
| ITI, Inc. | $153.59 | 7 | $0 (2023) |
| Axsome Therapeutics, Inc. | $140.76 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $136.81 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,041 | 76 | ABBVIE INC. ($354.71) |
| 2023 | $1,836 | 127 | ABBVIE INC. ($494.71) |
| 2022 | $1,501 | 129 | ABBVIE INC. ($378.74) |
| 2021 | $662.44 | 41 | AbbVie Inc. ($148.36) |
All Payment Transactions
373 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: PSYCHIATRY | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $58.22 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: CNS | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.61 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.26 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Insomnia | ||||||
| 11/12/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $11.48 | General |
| Category: CNS | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: PSYCHIATRY | ||||||
| 10/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: CNS | ||||||
| 10/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Neuropsychiatry | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.52 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: CNS | ||||||
| 10/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $2.00 | General |
| Category: CNS | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Central Nervous System | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Neuroscience | ||||||
| 09/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 51 | 217 | $34,770 | $9,868 |
| 2022 | 3 | 100 | 275 | $35,097 | $11,942 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 109 | $22,890 | $5,917 | 25.9% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2023 | 24 | 108 | $11,880 | $3,951 | 33.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 107 | $18,614 | $5,948 | 32.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Facility | 2022 | 27 | 100 | $9,285 | $3,830 | 41.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 23 | $3,659 | $882.01 | 24.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 14 | 22 | $1,859 | $730.08 | 39.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 23 | $1,679 | $551.81 | 32.9% |
About Ashley Dillon
Ashley Dillon is a Psychiatric/Mental Health healthcare provider based in Grand Island, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2021. The National Provider Identifier (NPI) number assigned to this provider is 1427628361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Dillon has received a total of $5,040 in payments from pharmaceutical and medical device companies, with $1,041 received in 2024. These payments were reported across 373 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($4,965).
As a Medicare-enrolled provider, Dillon has provided services to 151 Medicare beneficiaries, totaling 492 services with total Medicare billing of $21,810. Data is available for 2 years (2022–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Grand Island, NE
- Active Since 07/01/2021
- Last Updated 09/15/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1427628361
Products in Payments
- VRAYLAR (Drug) $1,377
- REXULTI (Drug) $683.05
- ARISTADA (Drug) $680.31
- INVEGA SUSTENNA (Drug) $497.59
- INGREZZA (Drug) $227.07
- AUSTEDO (Drug) $179.57
- CAPLYTA (Drug) $174.61
- ABILIFY MAINTENA (Drug) $142.07
- Auvelity (Drug) $140.76
- LATUDA (Drug) $136.81
- Austedo XR (Drug) $126.88
- QUVIVIQ (Drug) $110.22
- PERSERIS (Drug) $96.04
- ABILIFY ASIMTUFII (Drug) $80.01
- SPRAVATO (Drug) $76.08
- COBENFY (Drug) $58.22
- Azstarys (Drug) $53.75
- HETLIOZ (Drug) $43.12
- TRINTELLIX (Drug) $41.89
- VYVANSE (Drug) $35.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Grand Island
Linda Berry, Aprn, APRN
Psychiatric/Mental Health — Payments: $4,440
Chelsea Johnson, Aprn, APRN
Psychiatric/Mental Health — Payments: $3,875
Jennifer Murray, Fnp, FNP
Psychiatric/Mental Health — Payments: $3,196
Cheryl Lockett, Aprn, APRN
Psychiatric/Mental Health — Payments: $898.25
Mrs. Celianne Bacon, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $749.81
Bailey Binkey, Np, NP
Psychiatric/Mental Health — Payments: $58.45